<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Regression of CD30-positive large cell transformation arising on patch lesion of early mycosis fungoides.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Regression of CD30-positive large cell transformation arising on patch lesion of early mycosis fungoides." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752389/bin/CCR3-8-2418-g002.jpg"/> </div> <div class="text-side"> <h1>Regression of CD30-positive large cell transformation arising on patch lesion of early mycosis fungoides.</h1> <p>Clinical manifestations during the course of the disease. A, Macroscopic findings at two years after the first visit. Two ulcerative tumors are evident on MF patch lesions of the left chest. B, Histopathological findings of the tumor (hematoxylin‐eosin stain, loupe image). Nodular infiltration of tumor cells is evident in the dermis and subcutis. C, Histopathological findings of the tumor (hematoxylin‐eosin stain, ×400). Some nests consist of anaplastic large cells. D, Histopathological findings of the tumor (hematoxylin‐eosin stain, ×400). Small‐sized atypical lymphocyte‐like hyperchromatic cells have proliferated in the tumor. E, Immunohistochemical examination of the tumor using anti‐CD30 antibody (Roche, Basel, Switzerland) (loupe image). Anti‐CD30 antibodies are reactive to nearly half of the cells in the tumor. F, Immunohistochemical examination using anti‐CD30 antibody (×400). Anti‐CD30 antibodies are reactive to anaplastic large cells. G, Immunohistochemical examination using anti‐CD30 antibody (×400). Anti‐CD30 antibodies are not reactive to small atypical cells. H, Immunohistochemical examination using anti‐CXCR3 antibody (R&amp;D Systems, Minneapolis, MN) (×100). Anti‐CXCR3 antibodies are reactive to anaplastic large cells. I, Immunohistochemical examination using anti‐CCR3 antibody (R&amp;D systems) (×100). Anti‐CCR3 antibodies are not reactive to anaplastic large cells. J, Macroscopic findings at 3 mo after the initial appearance of the tumors. The tumors regressed spontaneously, leaving scars</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33363752/" target="_blank">33363752</a></p><p>Type: Premalignant/Malignant, Category: Hematolymphoid</p>
</div> </div></div></body></html>